Science and Technology News and Videos
Promising early data from an experimental trial of a new obesity treatment pill has sent shares of Danish pharmaceutical Novo Nordisk skyrocketing,
In previous trials, Wegovy led to participants losing six percent of their weight after 12 weeks, and 15 percent after 68 weeks.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Weight-Loss Drug Amycretin Has Patients Losing 13% of Body Weight in Just 3 MonthsDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »
Popularity of Ozempic's use for weight loss prompts new bill from New York City CouncilmemberDiabetes drugs like Ozempic have gained popularity for weight loss, but a New York City Council member is hoping to raise more awareness about side effects with a new bill.
Read more »
Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drugLars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.
Read more »
Experimental weight loss pill seems to be more potent than OzempicTaking the oral pill amycretin resulted in people losing 13 per cent of their body weight over three months, more than twice that seen with Ozempic, but larger and longer studies are needed
Read more »
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Read more »
Ricki Lake Shows Off Her 30-pound Weight Loss In New PicFrancesca Gariano is a New York City-based freelance journalist reporting on culture, entertainment, beauty, lifestyle and wellness. She is a freelance contributor to TODAY.com, where she covers pop culture and breaking news.
Read more »